We are live on ! Find out more
M.D. Sass

M.D. Sass Portfolio holdings

AUM $3.31B Turnover 9.52%
1-Year Est. Return 22.27%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+22.27%
3 Year Est. Return
+76.78%
5 Year Est. Return
+94.03%
10 Year Est. Return
+298.99%
AUM
$1.19B
AUM Growth
-$336M
Cap. Flow
-$519M
Cap. Flow %
-43.47%
Top 10 Hldgs %
47.76%
Holding
60
New
9
Increased
5
Reduced
31
Closed
8
Avg Time Held Equity + Options
1.5 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
1.4 years
Avg Time Held Equity only
1.6 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.6 years

Sector Composition

Rank Sector Weight
1 Healthcare 17.83%
2 Miscellaneous 15.44%
3 Financials 13.02%
4 Technology 12.43%
5 Consumer Discretionary 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$748B
$183M 15.31%
727,500
+589,500
+427% +$145M
2017 Q1
2 quarters
CELG
2
DELISTED
Celgene
CELG
$56M 4.7%
384,389
-259,890
-40% -$35.4M
2016 Q2
5 quarters
SHPG
3
DELISTED
Shire
SHPG
$47.2M 3.95%
308,022
-150,530
-33% -$23.6M
2014 Q4
11 quarters
AER icon
4
AerCap
AER
$25.3B
$45.9M 3.85%
898,763
-595,015
-40% -$29.2M
2014 Q1
14 quarters
DAL icon
5
Delta Air Lines
DAL
$54.2B
$44.6M 3.73%
924,297
-359,290
-28% -$17.9M
2013 Q4
15 quarters
AGN
6
DELISTED
Allergan plc
AGN
$43.7M 3.66%
213,087
-102,178
-32% -$23.8M
2013 Q2
17 quarters
EQT icon
7
EQT
EQT
$31B
$40.7M 3.41%
1,145,048
-645,946
-36% -$22M
2016 Q2
5 quarters
DFS icon
8
DELISTED
Discover Financial Services
DFS
$38.6M 3.23%
598,201
-512,205
-46% -$31.1M
2015 Q1
10 quarters
TER icon
9
Teradyne
TER
$33.1B
$37.1M 3.11%
+994,850
New +$34.4M
2017 Q3
0 quarters
CMCSA icon
10
Comcast
CMCSA
$89.9B
$33.6M 2.82%
+873,460
New +$34.4M
2017 Q3
0 quarters
ARRS
11
DELISTED
Arris International
ARRS
$33M 2.77%
1,159,314
-1,031,140
-47% -$28.5M
2015 Q1
10 quarters
LEN icon
12
Lennar Class A
LEN
$19.9B
$32.1M 2.69%
639,067
-397,296
-38% -$19.8M
2015 Q3
8 quarters
SYF icon
13
Synchrony
SYF
$21.6B
$32.1M 2.69%
1,032,300
-714,225
-41% -$21.4M
2016 Q4
3 quarters
VISN icon
14
Vistance Networks
VISN
$784M
$30M 2.52%
904,540
-272,295
-23% -$9.3M
2015 Q2
9 quarters
LVNTA
15
DELISTED
Liberty Interactive Series A Liberty Ventures
LVNTA
$28.9M 2.42%
+502,880
New +$29.1M
2017 Q3
0 quarters
GILD icon
16
Gilead Sciences
GILD
$210B
$28.1M 2.35%
346,515
-289,305
-46% -$22.1M
2015 Q1
10 quarters
MET icon
17
MetLife
MET
$61.8B
$28.1M 2.35%
540,061
-495,608
-48% -$24.1M
2013 Q2
17 quarters
GLPI icon
18
Gaming and Leisure Properties
GLPI
$11.2B
$26.1M 2.19%
707,123
-815,773
-54% -$30.8M
2013 Q4
15 quarters
KEYS icon
19
Keysight
KEYS
$45.9B
$24.7M 2.07%
594,010
+297,815
+101% +$12.2M
2017 Q2
1 quarter
DD icon
20
DuPont de Nemours
DD
$19.7B
$23.7M 1.98%
134,976
-134,803
-50% -$22.5M
2016 Q4
3 quarters
HOUS icon
21
DELISTED
Anywhere Real Estate
HOUS
$23.6M 1.98%
717,344
-879,980
-55% -$29.7M
2013 Q4
15 quarters
NCLH icon
22
Norwegian Cruise Line
NCLH
$7.65B
$23.2M 1.94%
428,495
-82,925
-16% -$4.64M
2017 Q2
1 quarter
DG icon
23
Dollar General
DG
$30.1B
$22.7M 1.9%
280,430
-132,165
-32% -$9.9M
2016 Q1
6 quarters
SGI icon
24
Somnigroup International
SGI
$13.7B
$21.7M 1.82%
1,346,900
-1,280,892
-49% -$18.9M
2015 Q3
8 quarters
CB icon
25
Chubb
CB
$144B
$21.2M 1.77%
148,539
-178,540
-55% -$25.8M
2016 Q1
6 quarters

Similar funds

M.D. Sass's Q3 2017 Portfolio in Review

As of Q3 2017, M.D. Sass held 60 positions worth $1.19B, down 22% from $1.53B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

M.D. Sass withdrew a net $519M in Q3 2017, closing 8 positions and reducing 31 holdings. Its most notable exit was Anadarko Petroleum, an estimated $25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, M.D. Sass opened a new position in Teradyne worth $37.1M.

  • M.D. Sass's largest Q3 2017 buy was Teradyne: 994,850 shares worth $37.1M.
  • M.D. Sass added most to Keysight in Q3 2017, an estimated $12.2M increase.
  • M.D. Sass's biggest Q3 2017 reduction was Cognizant, cutting an estimated $50.8M.
  • M.D. Sass fully exited Anadarko Petroleum in Q3 2017, selling an estimated $25M.
  • M.D. Sass's ten largest holdings make up 48% of its $1.19B portfolio in Q3 2017.
  • M.D. Sass opened 9 new positions and closed 8 in Q3 2017.
  • M.D. Sass's portfolio value fell 22% quarter-over-quarter to $1.19B.

Based on M.D. Sass's 13F filing for Q3 2017, filed 13 Nov 2017.